Remove 2011 Remove Compounding Pharmacies Remove Documentation
article thumbnail

STAT+: Pharmalittle: We’re reading about Novo targeting compounded obesity drugs, an Amgen ‘at risk’ launch, and more

STAT

Food and Drug Administration to bar compounding pharmacies from making copies of its blockbuster weight loss drug semaglutide, arguing that the medication is too complex for the pharmacies to safely make , STAT reports. regulators in 2011. … Novo Nordisk has asked the U.S. Last year, the drug generated $5.89